173 related articles for article (PubMed ID: 36792375)
1. Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke.
Ha J; Choi DW; Kim KJ; Kim KY; Nam CM; Kim E
Neurology; 2023 Apr; 100(17):e1799-e1811. PubMed ID: 36792375
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case-control study.
Ha J; Choi DW; Kim KY; Nam CM; Kim E
Cardiovasc Diabetol; 2021 Jul; 20(1):152. PubMed ID: 34315501
[TBL] [Abstract][Full Text] [Related]
3. Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case-control study.
Woo MH; Lee HS; Kim J
Cardiovasc Diabetol; 2019 May; 18(1):67. PubMed ID: 31151454
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study.
Hung YC; Chiu LT; Huang HY; Bau DT
Cardiovasc Diabetol; 2020 Jun; 19(1):94. PubMed ID: 32563247
[TBL] [Abstract][Full Text] [Related]
5. Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study.
Yoo J; Jeon J; Baik M; Kim J
Cardiovasc Diabetol; 2023 May; 22(1):106. PubMed ID: 37147722
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
Liu CH; Lee TH; Lin YS; Sung PS; Wei YC; Li YR
Cardiovasc Diabetol; 2020 Jan; 19(1):2. PubMed ID: 31910836
[TBL] [Abstract][Full Text] [Related]
7. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
Lincoff AM; Wolski K; Nicholls SJ; Nissen SE
JAMA; 2007 Sep; 298(10):1180-8. PubMed ID: 17848652
[TBL] [Abstract][Full Text] [Related]
9. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
Graham DJ; Ouellet-Hellstrom R; MaCurdy TE; Ali F; Sholley C; Worrall C; Kelman JA
JAMA; 2010 Jul; 304(4):411-8. PubMed ID: 20584880
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN; Viscoli CM; Furie KL; Young LH; Inzucchi SE; Gorman M; Guarino PD; Lovejoy AM; Peduzzi PN; Conwit R; Brass LM; Schwartz GG; Adams HP; Berger L; Carolei A; Clark W; Coull B; Ford GA; Kleindorfer D; O'Leary JR; Parsons MW; Ringleb P; Sen S; Spence JD; Tanne D; Wang D; Winder TR;
N Engl J Med; 2016 Apr; 374(14):1321-31. PubMed ID: 26886418
[TBL] [Abstract][Full Text] [Related]
11. Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.
Habib ZA; Tzogias L; Havstad SL; Wells K; Divine G; Lanfear DE; Tang J; Krajenta R; Pladevall M; Williams LK
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):437-47. PubMed ID: 19235778
[TBL] [Abstract][Full Text] [Related]
12. Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis.
Morgan CL; Inzucchi SE; Puelles J; Jenkins-Jones S; Currie CJ
Diabetes Obes Metab; 2018 Sep; 20(9):2140-2147. PubMed ID: 29732718
[TBL] [Abstract][Full Text] [Related]
13. Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study.
Seong JM; Choi NK; Shin JY; Chang Y; Kim YJ; Lee J; Kim JY; Park BJ
PLoS One; 2015; 10(5):e0124287. PubMed ID: 25992614
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone, SGLT2 inhibitors and their combination for primary prevention of cardiovascular disease and heart failure in type 2 diabetes: Real-world evidence from a nationwide cohort database.
Lo SC; Kornelius E; Liao PL; Huang JY; Yang YS; Huang CN
Diabetes Res Clin Pract; 2023 Jun; 200():110685. PubMed ID: 37100230
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
Spence JD; Viscoli C; Kernan WN; Young LH; Furie K; DeFronzo R; Abdul-Ghani M; Dandona P; Inzucchi SE
Diabetes Obes Metab; 2022 Jun; 24(6):1150-1158. PubMed ID: 35253334
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
Spence JD; Viscoli CM; Inzucchi SE; Dearborn-Tomazos J; Ford GA; Gorman M; Furie KL; Lovejoy AM; Young LH; Kernan WN;
JAMA Neurol; 2019 May; 76(5):526-535. PubMed ID: 30734043
[TBL] [Abstract][Full Text] [Related]
17. Risk of dementia according to the smoking habit change after ischemic stroke: a nationwide population-based cohort study.
Cheon DY; Han KD; Oh MS; Yu KH; Lee BC; Kim CH; Kim Y; Lee SH; Kim C; Lim JS; Lee M
Sci Rep; 2022 Dec; 12(1):22422. PubMed ID: 36575201
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone reduces cardiovascular events and dementia but increases bone fracture in elderly patients with type 2 diabetes mellitus: a national cohort study.
Yen CL; Wu CY; Tsai CY; Lee CC; Li YJ; Peng WS; Liu JR; Liu YC; Jenq CC; Yang HY; See LC
Aging (Albany NY); 2023 Apr; 15(7):2721-2733. PubMed ID: 37036483
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis.
Lee M; Saver JL; Liao HW; Lin CH; Ovbiagele B
Stroke; 2017 Feb; 48(2):388-393. PubMed ID: 27999139
[TBL] [Abstract][Full Text] [Related]
20. Detecting pioglitazone use and risk of cardiovascular events using electronic health record data in a large cohort of Chinese patients with type 2 diabetes.
Miao S; Dong X; Zhang X; Jing S; Zhang X; Xu T; Wang L; Du X; Xu H; Liu Y
J Diabetes; 2019 Aug; 11(8):684-689. PubMed ID: 30597747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
